Glycorex Transplantation AB (publ)

NGM:GTAB B Stock Report

Market Cap: SEK 174.3m

Glycorex Transplantation Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Johan Nilsson

Chief executive officer

SEK 1.1m

Total compensation

CEO salary percentage16.5%
CEO tenure2.3yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure2yrs

Recent management updates

Read This Before Buying Glycorex Transplantation AB (publ) (NGM:GTAB B) Shares

Feb 12
Read This Before Buying Glycorex Transplantation AB (publ) (NGM:GTAB B) Shares

How Much Is Glycorex Transplantation's (NGM:GTAB B) CEO Getting Paid?

Dec 21
How Much Is Glycorex Transplantation's (NGM:GTAB B) CEO Getting Paid?

Recent updates

Read This Before Buying Glycorex Transplantation AB (publ) (NGM:GTAB B) Shares

Feb 12
Read This Before Buying Glycorex Transplantation AB (publ) (NGM:GTAB B) Shares

How Much Is Glycorex Transplantation's (NGM:GTAB B) CEO Getting Paid?

Dec 21
How Much Is Glycorex Transplantation's (NGM:GTAB B) CEO Getting Paid?

CEO Compensation Analysis

How has Johan Nilsson's remuneration changed compared to Glycorex Transplantation's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-SEK 26m

Jun 30 2024n/an/a

-SEK 28m

Mar 31 2024n/an/a

-SEK 30m

Dec 31 2023SEK 1mSEK 187k

-SEK 30m

Sep 30 2023n/an/a

-SEK 16m

Jun 30 2023n/an/a

-SEK 11m

Mar 31 2023n/an/a

-SEK 9m

Dec 31 2022SEK 1mSEK 180k

-SEK 9m

Sep 30 2022n/an/a

-SEK 11m

Jun 30 2022n/an/a

-SEK 10m

Mar 31 2022n/an/a

-SEK 11m

Dec 31 2021SEK 859kSEK 414k

-SEK 12m

Sep 30 2021n/an/a

-SEK 11m

Jun 30 2021n/an/a

-SEK 9m

Mar 31 2021n/an/a

-SEK 14m

Dec 31 2020n/an/a

-SEK 8m

Sep 30 2020n/an/a

-SEK 5m

Jun 30 2020n/an/a

-SEK 2m

Mar 31 2020n/an/a

SEK 5m

Dec 31 2019SEK 909kSEK 832k

SEK 7m

Sep 30 2019n/an/a

SEK 7m

Jun 30 2019n/an/a

SEK 4m

Mar 31 2019n/an/a

SEK 4m

Dec 31 2018SEK 834kSEK 756k

SEK 3m

Compensation vs Market: Johan's total compensation ($USD102.34K) is below average for companies of similar size in the Swedish market ($USD230.11K).

Compensation vs Earnings: Johan's compensation has increased whilst the company is unprofitable.

CEO

Johan Nilsson (39 yo)

2.3yrs

Tenure

SEK 1,135,000

Compensation

Mr. Johan Nilsson serves as Acting Chief Executive Officer at Glycorex Transplantation AB (publ). He served as Director at Glycorex Transplantation AB (publ) until February 2021. Mr. Nilsson holds Bachelor...

Board Members

NamePositionTenureCompensationOwnership
Kurt Nilsson
Chairman of the Board29yrsSEK 492.00k1.18%
SEK 2.1m
Tomas Westergren
Deputy Director13yrsno datano data
Roland Frosing
Directorless than a yearno datano data
Joakim Jagorstrand
Director2yrsSEK 11.30kno data
Fredrik Johansson
Director2yrsSEK 11.30kno data

2.0yrs

Average Tenure

60yo

Average Age

Experienced Board: GTAB B's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/07 05:15
End of Day Share Price 2025/01/07 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Glycorex Transplantation AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution